Debn
1 known investors
Find your way into Debn
Sign up to see every warm intro you have to Debn
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Debn team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.
Investors · 1
Frequently asked questions
- What does Debn do?
- DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.
- Who are Debn's investors?
- Debn's investors include Alfabeat.
